In PC-3 tumor-bearing nude mice, flow cytometric analysis of splenocytes revealed that Cu-GM treatment significantly enhanced systemic immune activation, showing that the proportions of CD3+CD8+ T cells and CD3+CD4+ T cells were elevated by 3.4-fold and 3.3-fold, respectively, compared to the control group. Here, CD8A is linked to neoplasm.